Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
To add new flow synthesis and ozonolysis technologies.
January 15, 2025
By: Kristin Brooks
Managing Editor, Contract Pharma
Navin Molecular, a CDMO headquartered in India with small molecule development and manufacturing capabilities, is investing $1.2 million to construct a new 1,200-square-meter R&D facility at its site in Dewas, India. The new facility will increase the capacity for laboratory- and kilo-scale process development, as well as enhance analytical development and testing capabilities to support the development and scale up of customer projects.
The new building will have 48 fume hoods for chemical process development and will have specialized technology installed to carry out flow reactions and ozonolysis, as well as the capabilities to safely handle a wide range of hazardous chemistries.
A new kilo-scale lab will be commissioned, with cylindrical vessels up to 100 liters in volume, to mimic conditions on the production plant, and provide flexible capacity to manufacture non-GMP batches of material for preclinical toxicology studies.
Additionally an analytical laboratory will be built, including state-of-the art instrumentation to support method validation and tech transfer of projects. The investment will also upgrade existing labs at Dewas.
Work began on the new facility in December 2024 and it is expected to be completed by May 2025. The expansion will create up to 65 new jobs, doubling the size of the R&D team.
“Robust and thorough process development is crucial to ensure the chance of successful scale up, and customers are looking for partners that are flexible and have the capacity to take on projects with the minimum of delay to meet their demanding timelines,” said Jordi Robinson, Chief Commercial Officer at Navin Molecular. “This expansion will ensure that we can match these expectations, as well as increasing our technology offering through flow chemistry and ozonolysis, ensuring that we can continue to provide the highest quality, cost-effective manufacturing solutions for our customers.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !